1. Home
  2. Analysis
  3. Zopiclone
  4. Micronor

Zopiclone and Micronor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zopiclone and Micronor. Common interactions include constipation among females.

The phase IV clinical study analyzes what interactions people who take Zopiclone and Micronor have. It is created by eHealthMe based on reports of 20 people who take Zopiclone and Micronor from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 07, 2022

20 people who take Zopiclone and Micronor together, and have interactions are studied.

What is Zopiclone?

Zopiclone has active ingredients of eszopiclone. It is often used in insomnia. eHealthMe is studying from 42,615 Zopiclone users for its effectiveness, alternative drugs and more.

What is Micronor?

Micronor has active ingredients of norethindrone. It is often used in birth control. eHealthMe is studying from 1,265 Micronor users for its effectiveness, alternative drugs and more.

Number of Zopiclone and Micronor reports submitted per year:

Zopiclone and Micronor drug interactions.

Common Zopiclone and Micronor drug interactions by gender *:

female:

  1. Constipation
  2. Fatigue
  3. International normalised ratio increased
  4. Neoplasm malignant
  5. Platelet count increased
  6. Pulmonary embolism
  7. Rectal haemorrhage
  8. Vaginal haemorrhage
  9. Gastrointestinal disorder
  10. Pain in extremity

male:

n/a

Common Zopiclone and Micronor drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Colitis ulcerative
  2. Drug ineffective

30-39:

  1. Neoplasm malignant
  2. Platelet count increased

40-49:

  1. Vaginal haemorrhage
  2. Headache
  3. Heart rate increased
  4. Infusion related reaction
  5. International normalised ratio increased
  6. Pulmonary embolism
  7. Rectal haemorrhage

50-59:

  1. Constipation
  2. Fatigue
  3. Gastrointestinal disorder
  4. Pain in extremity

60+:

n/a

Common conditions people have *:

  1. Stress And Anxiety: 13 people, 65.00%
  2. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 12 people, 60.00%
  3. Pain: 10 people, 50.00%
  4. Osteoporosis (bones weak and more likely to break): 10 people, 50.00%
  5. Abdominal Pain Upper: 9 people, 45.00%
  6. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 2 people, 10.00%
  7. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 5.00%
  8. Psychotic Disorder: 1 person, 5.00%
  9. Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 1 person, 5.00%
  10. Muscle Spasms (muscle contraction): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Zopiclone and Micronor?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Zopiclone and Micronor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Zopiclone side effects:

Browse all side effects of Zopiclone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Zopiclone interactions:

Browse all interactions between Zopiclone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on eszopiclone and norethindrone (the active ingredients of Zopiclone and Micronor, respectively), and Zopiclone and Micronor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Zopiclone and Micronor.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.